AstraZeneca PLC - Total Other Finance Cost

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Finance-Cost" stands at 0.0835 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

AstraZeneca PLC's third quarter result of 0.085 Billion USD for the item "Total Other Finance Cost" represents an increase of 824.45 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 0.085 Billion USD for the item "Total Other Finance Cost" represents an increase of 731.13 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of 0.0835 Billion USD for the item "Total Other Finance Cost" represents an increase of 656.15 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.1395 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.1395 Billion United States Dollars.
The 3 year change is 0.0464 Billion United States Dollars.
The 5 year change is 0.122 Billion United States Dollars.
The 10 year change is 1.13 Billion United States Dollars.

The Serie's long term average value is -0.605 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.689 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2017, to it's latest available value, on 09/30/2025, is +1.67 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 Billion.